These are the biggest trends in clean tech in 2021

Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care

Can tech for good be as profitable as plain old tech?

Biopharma Collaboration Is Key For Innovation

Analyst shares the impact of ML applications in LS

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Why venture capital should be treated as a science not as an art

Family Offices Become Serious Rivals to VC Firms

VC Firms Have Long Backed AI. Now, They Are Using It.

Investment Into Biosciences Boomed, Could The Bubble Burst?